EN
中文 EN
  • 580+

    Peer-reviewed Articles

    UP TO 2024.08

  • 3728+

    lmpact Factor

  • 25+

    Tumor Types Involved

Cancer Cell | 10-Jan-22
Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma
Learn More
Frontiers in Oncology丨04-Jan-23
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receivingfirst-line chemotherapy
Volume 12 - 2022
Learn More
Cancer Cell | 13-Sep-21
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): a multicenter phase 3 study
Learn More
Cancer Cell | 13-Sep-21
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): a multicenter phase 3 study
Published: 12 April 2021
Learn More
Journal of Thoracic Oncology | Mar-21
Brigatinib After Progression From Alectinib or Crizotinib: Paving the Way for Treatment Sequencing of ALK Inhibitors in ALK-Positive NSCLC
Learn More
5 6 7 8 9 10
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."